Safety Study of Albuterol Spiromax® in Subjects With Asthma

Study Title

Safety Study of Albuterol Spiromaxֲ® in Subjects With Asthma

Teva Identifier

ABS-AS-307

ClinicalTrials.gov Identifier

NCT01698320

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Placebo MDPI | Drug: Albuterol MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

10/01/2012 - 12/01/2013

Phase

Phase 3

Study Type

Interventional